ホーム › 膵臓がん › テキサス

テキサスにおける膵臓がんの臨床試験

テキサス内の拠点で、膵臓がんに関する78件の研究が参加者を募集しています。

テキサス内の都市

公式研究テキスト（英語）

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START), San Antonio

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Texas Oncology - West Texas, Abilene
Texas Oncology - Austin, Austin
Texas Oncology - San Antonio, San Antonio
他1件

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/02更新 · NCT07562152

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

UT MD Anderson Cancer Center, Houston

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/02更新 · NCT05372614

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center - Conroe, Conroe
University of Texas MD Anderson Cancer Center, Houston
The University of Texas, MD Anderson Cancer Center - West Houston, Houston
他3件

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/01更新 · NCT07090499

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Houston
PHN-012-001 Site, San Antonio

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/29更新 · NCT07127874

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

University of Texas MD Anderson Cancer Center, Houston

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07621718

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

START Dallas Fort Worth, Fort Worth
MD Anderson, Houston
NEXT Oncology Houston, Houston
他1件

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413

DESTINY-PANTUMOUR04

Research Site, Dallas

被験者募集中観察研究

18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
他3件

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Texas Oncology - DFW, Dallas
University of Texas, Southwestern Medical Center, Dallas
University of Texas MD Anderson Cancer Center, Houston
他1件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/23更新 · NCT07252232

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

MD Anderson, Houston
NEXT Dallas, Irving
NEXT Oncology San Antonio, San Antonio
他1件

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

UT Southwestern Medical Center at Dallas, Dallas
Houston Methodist Office of Graduate - Houston Methodist Neal Cancer Center at Texas Medical Center, Houston

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07409272